Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

New England Journal of Medicine(2017)10.1056/nejmoa1611618Source: DataRank Database

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome is a research paper published in New England Journal of Medicine (2017). On theSindex it has a DataRank of 1.1. It has been cited 1,691 times.

N/A

1.1DataRank · unranked

Scored on demand from live citation data

1,691 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: bronzeTopics (14)Linked Datasets (25)DataCite Reuse (25)IDs (PubMed)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (0/2)

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

1.1

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (9)

J. Helen Cross ORCID,Linda Laux ORCID,Eric Marsh,Ian Miller ORCID,Rima Nabbout ORCID

Live enrichment

PubMed:28538134

National Institute for Health Research (NIHR)

Grant: NF-SI-0515-10073

bronzeLicense: other-oa

publisherhttps://www.nejm.org/doi/pdf/10.1056/NEJMoa1611618?articleTools=true

publisherhttp://www.nejm.org/doi/pdf/10.1056/NEJMoa1611618

repositoryhttps://discovery.ucl.ac.uk/1558984/1/Cross_nejmoa1611618.pdf

repositoryhttp://hdl.handle.net/20.500.11820/2ed5e0db-7de9-4411-93d7-3a5c388006b9

repositoryhttps://www.research.ed.ac.uk/en/publications/2ed5e0db-7de9-4411-93d7-3a5c388006b9

MeSH Terms

LiverHumansEpilepsies, MyoclonicSeizuresFatigueCannabidiolAnticonvulsantsLiver Function TestsDouble-Blind MethodAdolescentChildChild, PreschoolFemaleMale

Additional file 1 of Cannabinoid treatment for autism: a proof-of-concept randomized trial

10.6084/m9.figshare.13710521.v1figshare

Additional file 1 of Cannabinoid treatment for autism: a proof-of-concept randomized trial

10.6084/m9.figshare.13710521figshare

Additional file 2 of Cannabinoid treatment for autism: a proof-of-concept randomized trial

10.6084/m9.figshare.13710524.v1figshare

Additional file 2 of Cannabinoid treatment for autism: a proof-of-concept randomized trial

10.6084/m9.figshare.13710524figshare

Additional file 1 of Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis

10.6084/m9.figshare.17194168.v1figshare

Additional file 1 of Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis

10.6084/m9.figshare.17194168figshare

Additional file 1 of A mixed methods analysis of cannabis use routines for chronic pain management

10.6084/m9.figshare.18230843.v1figshare

Additional file 1 of A mixed methods analysis of cannabis use routines for chronic pain management

10.6084/m9.figshare.18230843figshare

Additional file 2 of A mixed methods analysis of cannabis use routines for chronic pain management

10.6084/m9.figshare.18230846.v1figshare

Additional file 2 of A mixed methods analysis of cannabis use routines for chronic pain management

10.6084/m9.figshare.18230846figshare

Additional file 1 of Healthcare provider and medical cannabis patient communication regarding referral and medication substitution: the Canadian context

10.6084/m9.figshare.20064224.v1figshare

Additional file 1 of Healthcare provider and medical cannabis patient communication regarding referral and medication substitution: the Canadian context

10.6084/m9.figshare.20064224figshare

Additional file 1 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

10.6084/m9.figshare.20517164.v1figshare

Additional file 1 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

10.6084/m9.figshare.20517164figshare

Additional file 2 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

10.6084/m9.figshare.20517167.v1figshare

Additional file 2 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

10.6084/m9.figshare.20517167figshare

Additional file 3 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

10.6084/m9.figshare.20517173.v1figshare

Additional file 3 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

10.6084/m9.figshare.20517173figshare

Additional file 4 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

10.6084/m9.figshare.20517176.v1figshare

Additional file 4 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

10.6084/m9.figshare.20517176figshare

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

FAIR Checklist

DataRank Breakdown

Authors (9)

Funding (1 grants)

Open Access

Topics

Linked Datasets (25)

Annotations (Europe PMC)